SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-044814
Filing Date
2020-09-28
Accepted
2020-09-28 16:15:29
Documents
2
Effectiveness Date
2020-09-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A srne-defa14a_20201016.htm DEFA14A 38348
2 GRAPHIC graiuiylbwb0000001.jpg GRAPHIC 4411
  Complete submission text file 0001564590-20-044814.txt   45681
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36150 | Film No.: 201204495
SIC: 2836 Biological Products, (No Diagnostic Substances)